Jan 03 2025

Florida Medical Marijuana Sales Top $145 Million in December, Bringing 2024 Total to Above $1.8 Billion

Florida’s medical marijuana industry continued its strong performance in December, with $145,551,582 in sales reported.

oregon marijuana sales

This brings the year-to-date total for 2024 to an impressive $1.81 billion, reaffirming Florida’s position as the largest medical marijuana market in the nation. This is according to data released by the research firm Headset.

Dried marijuana flower remained the most popular category among purchases in December, followed by vape pens, edibles, concentrates, tinctures, capsules, and topicals.
Continue reading

Jan 03 2025

California Surpasses $4 Billion in Legal Marijuana Sales for 2024 With $332 Million Sold in December

Marijuana sales in California reached $332 million in December, according to data from the Seattle-based research firm Headset.

While this marked a decrease from the $346 million reported in November, it brought the state’s total marijuana sales for 2024 to an impressive $4.2 billion.

These sales generated over $900 million in tax revenue for the state in 2024. Dried marijuana flower remained the top-selling category, followed by vape pens, prerolls, edibles, and concentrates. The average price per gram of dried flower in December was $8.62, or $23.32 per eighth, while concentrates averaged $16.24 per gram. Blue Dream retained its position as the most popular strain of the month.
Continue reading

Jan 03 2025

Rhode Island: Marijuana Sales Top $10 Million in December, $123 Million in 2024

In Rhode Island, December marked the fifth month this year with sales above $10 million.

The Rhode Island Department of Business Regulation reports that legal marijuana sales in December totaled $10.11 million, with $8.32 million attributed to recreational sales and $1.79 million to medical marijuana.

December’s figures bring the 2024 total to $118,321,577 across 3.2 million transactions.
Continue reading

Jan 03 2025

A Single-Dose of Psilocybin Could Help Treat Severe Treatment-Resistant Depression, Finds Study.

A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry.

The research, conducted by teams from Columbia University, Stanford University School of Medicine, and the University of Maryland, aimed to evaluate the safety and efficacy of psilocybin in individuals who had failed to respond to at least five prior treatments.

The study involved 12 participants aged 18-65, all experiencing a major depressive episode with documented resistance to conventional treatments. Conducted at Sheppard Pratt Hospital, the trial required participants to discontinue psychotropic medications two weeks before and three weeks after receiving a 25 mg dose of synthetic psilocybin. Patients underwent multiple therapy sessions before, during, and after the dosing period.
Continue reading

Jan 03 2025

Cost of Marijuana in Oregon Drops to All-Time Low for Third Straight Month, Remains By Far the Lowest in the U.S.

The average price of dried marijuana flower in Oregon continues to plummet, reaching an all-time low of $3.51 per gram in December, according to the Oregon Liquor and Cannabis Commission (OLCC).

This marks the third consecutive month of prices dropping to a new low. By comparison, in October 2016, when the state first began licensed recreational marijuana sales, the average price was $10.50 per gram—nearly three times higher than today’s rates.

Oregon’s marijuana concentrate market has also seen significant price reductions. In December, concentrates were priced at an average of $15.83, slightly above the record low of $15.36 set in April 2024 but a sharp decline from $40 per gram in October 2016.
Continue reading

Jan 02 2025

Texas Agriculture Commissioner Wants Medical Marijuana Law Expanded to “Include Far More Medical Conditions”

Texas Agriculture Commissioner Sid Miller has voiced strong support for expanding the state’s medical marijuana program to include more qualifying conditions, while reiterating his opposition to the unregulated marijuana market that has emerged across the state.

Miller, a long-time advocate for medical marijuana, expressed concern over the lack of safety standards and oversight in Texas’ burgeoning market for cannabis-derived products. He criticized the current situation as a “wild west” where unregulated cannabis items, including edibles and vape pens, are sold without proper safety inspections or chemical analyses.

While acknowledging the challenges posed by the state’s existing laws, Miller emphasized his belief in the potential benefits of medical marijuana. “I strongly support medical marijuana and our state’s compassionate use program,” Miller said in a press release sent today. “In fact, I want to see it expanded to include far more medical conditions than it currently does. Everyone who can benefit from it to help with their legitimate medical condition should have it available to them.”
Continue reading

Jan 02 2025

Oregon: $960 Million in Legal Marijuana Sold in 2024, Resulting in $163 Million in Taxes

There was nearly $1 billion in marijuana and marijuana products sold legally in Oregon in 2024.

(Photo credit: Getty Images).

According to the Oregon Liquor and Cannabis Commission, the state saw $78,553,980 in marijuana sales in December, bringing the total for 2024 to $960 million, and bringing the all-time total to $7.18 billion.

The $960 million in marijuana sold in 2024 resulted in $163 million in tax revenue for the state (this does not include the up to 3% local tax implemented by some cities). Revenue from the state’s 17% marijuana excise tax is allocated as follows: 40% to the State School Fund, 20% to mental health and treatment services, 15% to the State Police, 20% to local law enforcement, and 5% to the Oregon Health Authority for drug treatment and prevention programs.
Continue reading

Jan 02 2025

Nevada Lawmaker Named Co-Chair of U.S. Congressional Cannabis Caucus

Congressmember Dina Titus, a self-described “long-standing advocate for reforming the nation’s marijuana laws”, announced today she has been appointed co-chair of the Congressional Cannabis Caucus. Congressmember Ilhan Omar (D-MN) will serve as the other co-chair.

“I am honored to serve in a leadership position to help shape our nation’s marijuana policies,” Congressmember Titus said in a press release sent today. “Whether it is access to banking services and regular tax treatment for cannabis businesses, veteran use of cannabis for medicinal purposes through the Veterans Administration, or pushing the federal government to reform its outdated scheduling of marijuana as a dangerous drug, there is much work to be done.”

Titus continues: “In Nevada and the 23 other states that have decriminalized marijuana, the cannabis industry has demonstrated it is a responsible industry. It is time for the federal government to recognize that and treat it accordingly.”
Continue reading

Jan 02 2025

Clinical Trial: Psilocybin Promotes Lasting Positive Personality Changes in Patients With Alcohol Use Disorder

According to the results of a new clinical trial, psilocybin holds promise as a tool for reshaping personality traits in people battling alcohol addiction.

Dried psilocybin mushrooms.

Researchers from New York University, the University of New Mexico School of Medicine, NYU Grossman School of Medicine, and Arizona State University conducted a randomized controlled trial to explore the effects of psilocybin-assisted therapy (PAT) on personality dimensions in individuals with alcohol use disorder (AUD).

The study, published in the American Journal of Psychiatry, involved 84 adults diagnosed with AUD. Participants were randomized to receive two sessions of either psilocybin or an active placebo (diphenhydramine), alongside 12 weekly psychotherapy sessions and a 24-week follow-up period. Changes in personality were measured using the revised NEO Personality Inventory, and alcohol consumption was tracked via a timeline followback method.
Continue reading

Jan 01 2025

California Now Allows Amsterdam-Style Marijuana Cafés as New Law Takes Effect

Cities and counties across California can now authorize licensed cannabis retailers and microbusinesses to prepare and sell non-cannabis food and beverages and host live performances, as Assembly Bill 1775 officially goes into effect today, January 1, 2025.

The new law, signed by Governor Gavin Newsom in late September 2024 and sponsored by Assemblymember Matt Haney, marks a significant shift in the state’s approach to cannabis consumption spaces, allowing them to operate more like Amsterdam-style cafés. These establishments can now provide a more vibrant, community-oriented experience by offering freshly prepared food and drink alongside live music and other performances—all within spaces where cannabis consumption is permitted.

The bill, championed by its sponsors despite a veto of a similar measure in 2023, garnered strong bipartisan support in the legislature. It passed with a 58 to 6 vote in the Assembly and a 30 to7 vote in the Senate. Proponents argued that the previous restrictions, which limited lounges to offering only prepackaged food and drinks, hindered the potential of these spaces to thrive as social and cultural hubs.
Continue reading